Prudence Ive

3.7k total citations
48 papers, 2.0k citations indexed

About

Prudence Ive is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Prudence Ive has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 23 papers in Virology and 18 papers in Epidemiology. Recurrent topics in Prudence Ive's work include HIV/AIDS Research and Interventions (28 papers), HIV/AIDS drug development and treatment (27 papers) and HIV Research and Treatment (23 papers). Prudence Ive is often cited by papers focused on HIV/AIDS Research and Interventions (28 papers), HIV/AIDS drug development and treatment (27 papers) and HIV Research and Treatment (23 papers). Prudence Ive collaborates with scholars based in South Africa, United States and Uganda. Prudence Ive's co-authors include Ian Sanne, Wendy Stevens, Matthew P. Fox, Tobias F. Rinke de Wit, Kim Sigaloff, Raph L Hamers, Margaret Siwale, Cissy Kityo, Carole L. Wallis and Kishor Mandaliya and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Prudence Ive

46 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Prudence Ive South Africa	22	1.7k	950	702	177	176	48	2.0k
Mark S. Shaefer United States	24	1.5k 0.9×	1.1k 1.1×	419 0.6×	194 1.1×	438 2.5×	79	2.4k
Paul A. Pham United States	17	1000 0.6×	507 0.5×	457 0.7×	94 0.5×	375 2.1×	38	1.5k
Kristine B. Patterson United States	26	1.7k 1.0×	1.0k 1.1×	655 0.9×	53 0.3×	308 1.8×	60	2.2k
Richard Kaplan South Africa	26	1.8k 1.1×	715 0.8×	835 1.2×	146 0.8×	285 1.6×	52	2.0k
Kenneth A. Freedberg United States	10	1.2k 0.8×	538 0.6×	714 1.0×	137 0.8×	242 1.4×	15	1.5k
Eduardo Sprinz Brazil	26	1.5k 0.9×	968 1.0×	503 0.7×	116 0.7×	722 4.1×	92	2.2k
Anders Blaxhult Sweden	26	1.6k 0.9×	1.0k 1.1×	959 1.4×	80 0.5×	498 2.8×	73	2.2k
Albert Minga Ivory Coast	22	1.1k 0.7×	716 0.8×	547 0.8×	45 0.3×	238 1.4×	62	1.4k
Eugène Messou Ivory Coast	24	1.6k 1.0×	759 0.8×	953 1.4×	118 0.7×	362 2.1×	70	2.1k

Countries citing papers authored by Prudence Ive

Since Specialization

Citations

This map shows the geographic impact of Prudence Ive's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prudence Ive with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prudence Ive more than expected).

Fields of papers citing papers by Prudence Ive

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prudence Ive. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prudence Ive. The network helps show where Prudence Ive may publish in the future.

Co-authorship network of co-authors of Prudence Ive

This figure shows the co-authorship network connecting the top 25 collaborators of Prudence Ive. A scholar is included among the top collaborators of Prudence Ive based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prudence Ive. Prudence Ive is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richards, Lauren, David Spencer, Jeremy Nel, & Prudence Ive. (2020). Infectious disease consultations at a South African academic hospital: A 6-month assessment of inpatient consultations. SHILAP Revista de lepidopterología. 35(1). 169–169.

Ive, Prudence, Tom Boyles, Colleen Bamford, et al.. (2018). The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study. International Journal of Infectious Diseases. 73. 78–84. 8 indexed citations

Inzaule, Seth, Cissy Kityo, Margaret Siwale, et al.. (2018). Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance. Scientific Reports. 8(1). 15751–15751. 10 indexed citations

Ondoa, Pascale, Cissy Kityo, Margaret Siwale, et al.. (2018). Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. AIDS. 32(8). 1043–1051. 50 indexed citations

Rohr, Julia K., Prudence Ive, C. Robert Horsburgh, et al.. (2016). Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. PLoS ONE. 11(8). e0161469–e0161469. 29 indexed citations

Saharia, Kapil, Constantinos Petrovas, Sara Ferrando‐Martínez, et al.. (2016). Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells. PLoS ONE. 11(7). e0158262–e0158262. 20 indexed citations

Evans, Denise, et al.. (2016). Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study. South African Medical Journal. 106(10). 1002–1002. 15 indexed citations

Thiébaut, Rodolphe, Jean-Pierre Routy, Irini Sereti, et al.. (2016). Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies. Clinical Infectious Diseases. 62(9). 1178–1185. 61 indexed citations

Dawson, Rodney, Andreas H. Diacon, Daniel E. Everitt, et al.. (2015). Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. The Lancet. 385(9979). 1738–1747. 184 indexed citations

10.

Crump, John A., Xingye Wu, Michelle A. Kendall, et al.. (2015). Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study. BMC Infectious Diseases. 15(1). 12–12. 14 indexed citations

11.

Ive, Prudence, William MacLeod, Catherine Orrell, et al.. (2013). Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial. PLoS ONE. 8(12). e74900–e74900. 14 indexed citations

12.

Cooper, David A., Jayvant Heera, Prudence Ive, et al.. (2013). Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1. AIDS. 28(5). 717–725. 30 indexed citations

13.

Hamers, Raph L, Kim Sigaloff, Annemarie M. J. Wensing, et al.. (2012). Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies. Clinical Infectious Diseases. 54(11). 1660–1669. 137 indexed citations

14.

Sigaloff, Kim, Raph L Hamers, Carole L. Wallis, et al.. (2012). Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa. The Journal of Infectious Diseases. 205(11). 1739–1744. 55 indexed citations

15.

MacLeod, William, et al.. (2012). The Feasibility of Using Screening Criteria to Reduce Clinic Visits for Stable Patients on Antiretroviral Therapy in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(3). e82–e86. 4 indexed citations

16.

Sigaloff, Kim, Raph L Hamers, Carole L. Wallis, et al.. (2011). Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(1). 23–31. 151 indexed citations

17.

Brennan, Alana T., Denise Evans, Mhairi Maskew, et al.. (2011). Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir. AIDS. 25(13). 1603–1609. 80 indexed citations

18.

Hamers, Raph L, Rob Schuurman, Kim Sigaloff, et al.. (2011). Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. The Lancet Infectious Diseases. 12(4). 307–317. 141 indexed citations

19.

Westreich, Daniel, Patrick MacPhail, Annelies Van Rie, et al.. (2009). Effect of pulmonary tuberculosis on mortality in patients receiving HAART. AIDS. 23(6). 707–715. 35 indexed citations

20.

Ive, Prudence, et al.. (2006). Decreased sexual risk behaviour after the diagnosis of HIV and initiation of antiretroviral treatment - a study of patients in Johannesburg. Southern African Journal of HIV Medicine. 7(25). 12–14. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact